Clinical Trial Update: A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of SHR-A1811 in patients with advanced malignant solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• SHR-A1811

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED